{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:05:22Z","timestamp":1784739922198,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2022206355"],"award-info":[{"award-number":["H2022206355"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272909"],"award-info":[{"award-number":["82272909"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117400","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:31:29Z","timestamp":1759937489000},"page":"117400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Erbin destabilization by O-GlcNAcylation promotes 5-FU resistance via homologous recombination activation in colorectal cancer"],"prefix":"10.1016","volume":"243","author":[{"given":"Jianqing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weile","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9601-8210","authenticated-orcid":false,"given":"Guiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2025.117400_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.bcp.2025.117400_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071732","article-title":"Colorectal Cancer: a Review of Carcinogenesis, Global Epidemiology, current challenges, Risk Factors, Preventive and Treatment strategies","volume":"14","author":"Hossain","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2025.117400_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117400_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bcp.2025.117400_b0025","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/cas.14532","article-title":"5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes","volume":"111","author":"Blondy","year":"2020","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117400_b0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrm.2017.22","article-title":"Protein O-GlcNAcylation: emerging mechanisms and functions","volume":"18","author":"Yang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117400_b0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/physrev.00043.2019","article-title":"Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology","volume":"101","author":"Chatham","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2025.117400_b0040","doi-asserted-by":"crossref","unstructured":"Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40(10):1207-22.e10.","DOI":"10.1016\/j.ccell.2022.08.012"},{"issue":"7","key":"10.1016\/j.bcp.2025.117400_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071666","article-title":"O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer","volume":"13","author":"Parker","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12672-021-00450-5","article-title":"O-GlcNAcylation links oncogenic signals and cancer epigenetics","volume":"12","author":"Sun","year":"2021","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0055","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1038\/s41467-024-49875-w","article-title":"O-GlcNAcylation of MITF regulates its activity and CDK4\/6 inhibitor resistance in breast cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0060","doi-asserted-by":"crossref","first-page":"16992","DOI":"10.1038\/s41598-020-74083-z","article-title":"Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells","volume":"10","author":"Barkovskaya","year":"2020","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.bcp.2025.117400_b0065","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.7150\/thno.27806","article-title":"Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bcp.2025.117400_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060866","article-title":"Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by reducing O-GlcNAcylation in Hepatocellular Carcinoma","volume":"12","author":"Li","year":"2023","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.bcp.2025.117400_b0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/35017038","article-title":"ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2\/HER2 receptor","volume":"2","author":"Borg","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"17","key":"10.1016\/j.bcp.2025.117400_b0080","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1158\/0008-5472.CAN-17-3629","article-title":"Erbin Suppresses KSR1-Mediated RAS\/RAF Signaling and Tumorigenesis in Colorectal Cancer","volume":"78","author":"Stevens","year":"2018","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117400_b0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ymthe.2019.01.016","article-title":"miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin","volume":"27","author":"Zheng","year":"2019","journal-title":"Molecular Therapy : the Journal of the American Society of Gene Therapy."},{"issue":"6","key":"10.1016\/j.bcp.2025.117400_b0095","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jhep.2017.01.030","article-title":"Elevated expression of Erbin destabilizes ER\u03b1 protein and promotes tumorigenesis in hepatocellular carcinoma","volume":"66","author":"Wu","year":"2017","journal-title":"J. Hepatol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117400_b0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2013.04.007","article-title":"Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance","volume":"56","author":"Liu","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2025.117400_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216742","article-title":"Targeting O-GlcNAcylation in cancer therapeutic resistance: the sugar Saga continues","volume":"588","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.bcp.2025.117400_b0105","first-page":"4101","article-title":"ZEB1 promotes DNA homologous recombination repair and contributes to the 5-Fluorouracil resistance in colorectal cancer","volume":"13","author":"Wu","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research : CR."},{"key":"10.1016\/j.bcp.2025.117400_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1921609","article-title":"GFAT1\/HBP\/O-GlcNAcylation Axis Regulates \u03b2-Catenin activity to Promote Pancreatic Cancer Aggressiveness","volume":"2020","author":"Jia","year":"2020","journal-title":"Biomed Res. Int."},{"issue":"9","key":"10.1016\/j.bcp.2025.117400_b0120","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41388-018-0533-4","article-title":"IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells","volume":"38","author":"Shimizu","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117400_b0125","volume":"9","author":"Li","year":"2022"},{"issue":"11","key":"10.1016\/j.bcp.2025.117400_b0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41419-019-2034-y","article-title":"Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer","volume":"10","author":"Chokchaitaweesuk","year":"2019","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2025.117400_b0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10863-018-9751-2","article-title":"O-GlcNAc in cancer: an Oncometabolism-fueled vicious cycle","volume":"50","author":"Hanover","year":"2018","journal-title":"J. Bioenerg. Biomembr."},{"issue":"3","key":"10.1016\/j.bcp.2025.117400_b0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41388-018-0435-5","article-title":"O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc\/EZH2 regulatory feedback circuit","volume":"38","author":"Jiang","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bcp.2025.117400_b0145","first-page":"2193","article-title":"Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification","volume":"40","author":"Netsirisawan","year":"2018","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2025.117400_b0150","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41589-022-01085-5","article-title":"O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1","volume":"18","author":"Zhu","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117400_b0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/onc.2016.228","article-title":"O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway","volume":"36","author":"Ferrer","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2025.117400_b0160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3892\/mmr.2014.2269","article-title":"O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells","volume":"10","author":"Gu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2025.117400_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70037","article-title":"O-GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2","volume":"14","author":"Zhang","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117400_b0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41419-024-06729-z","article-title":"E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA","volume":"15","author":"Du","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2025.117400_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069150","article-title":"O-GlcNAcylation-inducing treatments inhibit estrogen receptor \u03b1 expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells","volume":"8","author":"Kanwal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117400_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101150","article-title":"O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma","volume":"77","author":"Zeng","year":"2024","journal-title":"Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy."},{"issue":"5","key":"10.1016\/j.bcp.2025.117400_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051162","article-title":"Targeted Inhibition of O-Linked \u03b2-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.bcp.2025.117400_b0190","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1158\/0008-5472.CAN-18-1991","article-title":"DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death","volume":"79","author":"Lee","year":"2019","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.bcp.2025.117400_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194740","article-title":"Inhibition of O-GlcNAcylation Reduces Cell Viability and Autophagy and increases Sensitivity to Chemotherapeutic Temozolomide in Glioblastoma","volume":"15","author":"Leonel","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.bcp.2025.117400_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109739","article-title":"DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation","volume":"36","author":"Song","year":"2021","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bcp.2025.117400_b0205","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.7150\/ijbs.89700","article-title":"A novel CSN5\/CRT O-GlcNAc\/ER stress regulatory axis in platinum resistance of epithelial ovarian cancer","volume":"20","author":"Yan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117400_b0210","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1158\/0008-5472.CAN-24-2492","article-title":"Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4\/6 Inhibitors in Breast Cancer","volume":"85","author":"Zhou","year":"2025","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117400_b0215","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jmb.2017.02.011","article-title":"When Worlds Collide-Mechanisms at the Interface between Phosphorylation and Ubiquitination","volume":"429","author":"Filip\u010d\u00edk","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117400_b0220","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1074\/mcp.R113.029751","article-title":"Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination","volume":"12","author":"Ruan","year":"2013","journal-title":"Molecular & Cellular Proteomics : MCP."},{"issue":"2","key":"10.1016\/j.bcp.2025.117400_b0225","first-page":"96","article-title":"O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress","volume":"1800","author":"Butkinaree","year":"2010","journal-title":"BBA"},{"issue":"8","key":"10.1016\/j.bcp.2025.117400_b0230","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cbf.3150","article-title":"PUGNAc induces protein ubiquitination in C2C12 myotube cells","volume":"33","author":"Park","year":"2015","journal-title":"Cell Biochem. Funct."},{"issue":"15","key":"10.1016\/j.bcp.2025.117400_b0235","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41388-024-02977-7","article-title":"O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation","volume":"43","author":"Feng","year":"2024","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcp.2025.117400_b0240","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0245","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/cas.14718","article-title":"dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells","volume":"112","author":"Yokogawa","year":"2021","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117400_b0250","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jat.1411","article-title":"5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line","volume":"29","author":"Matuo","year":"2009","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0255","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13046-023-02789-9","article-title":"SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation","volume":"42","author":"Liu","year":"2023","journal-title":"Journal of Experimental & Clinical Cancer Research : CR."},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13046-024-03078-9","article-title":"The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance","volume":"43","author":"Sanese","year":"2024","journal-title":"Journal of Experimental & Clinical Cancer Research : CR."},{"issue":"49","key":"10.1016\/j.bcp.2025.117400_b0265","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/s41388-021-02052-5","article-title":"PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair","volume":"40","author":"Cao","year":"2021","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bcp.2025.117400_b0270","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bcp.2008.08.010","article-title":"DNA damage and homologous recombination signaling induced by thymidylate deprivation","volume":"76","author":"Yang","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117400_b0275","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/mol.115.100164","article-title":"Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination","volume":"89","author":"Huehls","year":"2016","journal-title":"Mol. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:58:13Z","timestamp":1775797093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S0006295225006653"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117400","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erbin destabilization by O-GlcNAcylation promotes 5-FU resistance via homologous recombination activation in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117400"}}